Bank of America
INDP icon

Bank of America’s Indaptus Therapeutics INDP Stock Holding History

Bank of America’s Portfolio INDP Stock Details INDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-25
Closed -$73 – 6282
2025
Q4 		$73 Sell
25
-8
-24% -$23 ﹤0.01% 6886
2025
Q3 		$94 Buy
33
+2
+6% +$14 ﹤0.01% 7872
2025
Q2 		$327 Buy
31
+27
+675% +$315 ﹤0.01% 7749
2025
Q1 		$54 Buy
4
+2
+100% +$46 ﹤0.01% 7968
2024
Q4 		$51 Hold
2
– – ﹤0.01% 7859
2024
Q3 		$74 Hold
2
– – ﹤0.01% 7768
2024
Q2 		$89 Buy
+2
New +$133 ﹤0.01% 7727
2024
Q1 		– Hold
0
– -$5 – 7946
2023
Q4 		– Hold
0
– – – 7856
2023
Q1 		– Hold
0
– -$16 – 8022
2022
Q4 		– Hold
0
– – – 8016
2021
Q2 		– Sell
-283
Closed -$138K – 7885
2021
Q1 		$138K Buy
+283
New +$148K ﹤0.01% 6255
2020
Q4 		– Hold
0
– – – 7205
2020
Q3 		– Hold
0
– – – 7016
2020
Q2 		– Hold
0
– – – 6950
2019
Q4 		– Sell
-4
Closed -$7K – 7221
2019
Q3 		$7K Buy
+4
New +$11.9K ﹤0.01% 6782
2018
Q3 		– Hold
0
– -$1K – 7354
2018
Q2 		– Hold
0
– – – 6972
2018
Q1 		– Hold
0
– – – 6965
2017
Q4 		– Hold
0
– – – 7125
2017
Q3 		– Hold
0
– – – 6674

Other funds holding INDP

Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Bank of America's INDP Position: Q1 2026 in Review

Bank of America sold out of Indaptus Therapeutics (INDP) in Q1 2026, closing a stake of 25 shares — an estimated $73 sold.

Bank of America first reported a position in INDP in Q3 2019 and held it in 9 quarters. The position peaked at $138K in Q1 2021. 6 funds tracked by Wall St. Rank hold INDP as of Q1 2026.

  • Bank of America reported no remaining Indaptus Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 25 Indaptus Therapeutics shares in Q1 2026, an estimated $73.
  • Bank of America first reported a position in Indaptus Therapeutics in Q3 2019 and held it in 9 quarters.
  • Bank of America's Indaptus Therapeutics position peaked at $138K in Q1 2021.
  • 6 funds tracked by Wall St. Rank held Indaptus Therapeutics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.